ConductScience.org, home

Paper78795

Antineoplastic drugs: clinical pharmacology and therapeutic use.

Bender RA and 8 others. Drugs, 1978. Cited by 42 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antineoplastic drugs: clinical pharmacology and therapeutic use. Papers, record 78795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/78795

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antineoplastic drugs: clinical pharmacology and therapeutic use.
PubMed
Journal
Drugs
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.37
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bender RAR A
2Zwelling LAL A
3Doroshow JHJ H
4Locker GYG Y
5Hande KRK R
6Murinson DSD S
7Cohen MM
8Myers CEC E
9Chabner BAB A

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Alkaloids
Alkylating Agents
Antibiotics, Antineoplastic
Azacitidine
Bleomycin
Cisplatin
Cyclophosphamide
Cytarabine
Drug Interactions
Fluorouracil
Humans
Kinetics
Methotrexate
Podophyllotoxin

Source PubMed

References271

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,268,851The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line.Cancer Res1976https://conductscience.org/library/papers/1268851PubMed
24,114,341Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.Cancer1972https://conductscience.org/library/papers/4114341PubMed
34,586,953Cis-diamminedichloroplatinum (NSC-119875): a phase I study.Cancer Chemother Rep1973https://conductscience.org/library/papers/4586953PubMed
4942,583Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.Cancer Res1976https://conductscience.org/library/papers/942583PubMed
51,157,447PTG, a new antineoplastic epipodyphyllotoxin.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1157447PubMed
64,122,362A clinical review of bleomycin--a new antineoplastic agent.Cancer1973https://conductscience.org/library/papers/4122362PubMed
71,168,475Uptake and binding of vincristine by murine leukemia cells.Biochem Pharmacol1975https://conductscience.org/library/papers/1168475PubMed
8884,658The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.Cancer Res1977https://conductscience.org/library/papers/884658PubMed
9872,088Pharmacokinetics of vindesine and vincristine in humans.Cancer Res1977https://conductscience.org/library/papers/872088PubMed
101,184,747Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.J Clin Invest1975https://conductscience.org/library/papers/1184747PubMed
114,823,268Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man.J Nucl Med1974https://conductscience.org/library/papers/4823268PubMed
125,092,856The effect of prednisolone and other factors on the catabolism of 5-fluorouracil in rats.J Lab Clin Med1971https://conductscience.org/library/papers/5092856PubMed
131,268,859Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin.Cancer Res1976https://conductscience.org/library/papers/1268859PubMed
144,634,038Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).Cancer Chemother Rep1972https://conductscience.org/library/papers/4634038PubMed
155,349,626The effect of organic acids on renal clearance of methotrexate in man.Clin Pharmacol Ther1969https://conductscience.org/library/papers/5349626PubMed
161,273,807Adriamycin and fibrinolysis.Thromb Res1976https://conductscience.org/library/papers/1273807PubMed
174,578,134Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.Br Med J1973https://conductscience.org/library/papers/4578134PubMed
18766,582Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.Adv Cancer Res1975https://conductscience.org/library/papers/766582PubMed
194,548,188The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4548188PubMed
201,182,680Radiation-adriamycin interactions: preliminary clinical observations.Cancer1975https://conductscience.org/library/papers/1182680PubMed

See all 271 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
36,012,200Congo Red as a Supramolecular Carrier System for Doxorubicin: An Approach to Understanding the Mechanism of Action.Int J Mol Sci2022https://conductscience.org/library/papers/36012200PubMed
7,031,350[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].Klin Wochenschr1981https://conductscience.org/library/papers/7031350PubMed
6,680,116Modern cancer chemotherapy.Indian J Pediatr1983https://conductscience.org/library/papers/6680116PubMed
6,189,661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
3,839,754Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3839754PubMed
3,042,525Increase of corneal graft survival by use of topically immunosuppressive agents in rabbits.Graefes Arch Clin Exp Ophthalmol1988https://conductscience.org/library/papers/3042525PubMed
2,661,101Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.Clin Pharmacokinet1989https://conductscience.org/library/papers/2661101PubMed
2,656,050Clinical pharmacology of 5-fluorouracil.Clin Pharmacokinet1989https://conductscience.org/library/papers/2656050PubMed
465,283Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.Br J Clin Pharmacol1979https://conductscience.org/library/papers/465283PubMed
363,401Drug treatment of breast cancer.Drugs1978https://conductscience.org/library/papers/363401PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/78795

GET https://conductscience.org/api/papers/v1/78795/references?page=2